Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$2.42 - $6.6 $33,396 - $91,080
-13,800 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$5.6 - $11.0 $77,280 - $151,800
13,800 New
13,800 $78,000
Q2 2018

Aug 08, 2018

SELL
$6.16 - $10.14 $121,968 - $200,772
-19,800 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$6.53 - $9.82 $58,770 - $88,380
9,000 Added 83.33%
19,800 $139,000
Q4 2017

Feb 12, 2018

BUY
$6.12 - $12.31 $66,096 - $132,948
10,800
10,800 $106,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $73.2M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.